1/29
04:45 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Jan 26
Low
Report
Form 8-K AN2 Therapeutics, Inc. For: Jan 26
1/14
05:07 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Martin Patricia A.
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Martin Patricia A.
1/14
05:07 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Aziz Kabeer
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Aziz Kabeer
1/14
05:06 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Marks Gilbert Lynn
Medium
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 12 Filed by: Marks Gilbert Lynn
1/7
08:15 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Prior Stephen David
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Prior Stephen David
1/7
08:15 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Day Lucy
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Day Lucy
1/7
08:13 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Chanda Sanjay
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Chanda Sanjay
1/7
08:12 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Eizen Joshua M
High
Report
Form 4 AN2 Therapeutics, Inc. For: Jan 05 Filed by: Eizen Joshua M
11/14
07:51 pm
antx
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
Low
Report
Form SCHEDULE 13G AN2 Therapeutics, Inc. Filed by: Almitas Capital LLC
11/12
04:21 pm
antx
Form 10-Q AN2 Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q AN2 Therapeutics, Inc. For: Sep 30
11/12
04:20 pm
antx
Form 8-K AN2 Therapeutics, Inc. For: Nov 12
Medium
Report
Form 8-K AN2 Therapeutics, Inc. For: Nov 12
11/6
06:12 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Eizen Joshua M
11/6
06:11 pm
antx
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David
Low
Report
Form 4 AN2 Therapeutics, Inc. For: Nov 04 Filed by: Prior Stephen David